Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma

Human Pathology

Volumn 39, Issue 12, 2008, Pages 1827-1834

  Zhang, Shu Hui ^a   Xu, Ai Min ^b   Chen, Xin Fang ^c   Li, Di Hua ^a   Sun, Man Ping ^a   Wang, Yu Jia ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dysplastic nodules, Prognosis; MAD2, Hepatocellular carcinoma

Indexed keywords

MESSENGER RNA; PROTEIN MAD2;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DYSPLASIA; FEMALE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER NODULE; MAD2 GENE; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; CALCIUM-BINDING PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 55949109038     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.06.003     Document Type: Article

References (30)

1. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6 (2006) 674-687
2. Saeki A., Tamura S., Ito N., et al. Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. Cancer 94 (2002) 2047-2054
3. Rajagopalan H., Nowak M.A., Vogelstein B., and Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3 (2003) 695-701
4. Kops G.J., Weaver B.A., and Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5 (2005) 773-785
5. Guardavaccaro D., Frescas D., Dorrello N.V., et al. Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature 452 (2008) 365-369
6. Meng X., Yuan Y., Maestas A., and Shen Z. Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280. J Biol Chem 279 (2004) 6098-6105
7. Garber M.E., Troyanskaya O.G., Schluens K., et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 98 (2001) 13784-13789
8. Tanaka K., Nishioka J., Kato K., et al. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn J Cancer Res 92 (2001) 952-958
9. Rimkus C., Friederichs J., Rosenberg R., Holzmann B., Siewert J.R., and Janssen K.P. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int J Cancer 120 (2007) 207-211
10. Chen X., Cheung S.T., So S., et al. Gene expression patterns in human liver cancers. Mol Biol Cell 13 (2002) 1929-1939
11. Sze K.M., Ching Y.P., Jin D.Y., and Ng I.O. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells. J Biomed Sci 11 (2004) 920-927
12. Jeong S.J., Shin H.J., Kim S.J., et al. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis. Cancer Res 64 (2004) 8666-8673
13. Hamilton S., and Aaltonen L. World Health Organization classification of tumours: pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon 167-169
14. Xian Z.H., Zhang S.H., Cong W.M., Yan H.X., Wang K., and Wu M.C. Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma. Mod Pathol 19 (2006) 280-286
15. Ma S., Guan X.Y., Lee T.K., and Chan K.W. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol 38 (2007) 1201-1206
16. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
17. Tao X., Zheng J.M., Xu A.M., Chen X.F., and Zhang S.H. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol Res 37 (2007) 820-827
18. Hisaoka M., Matsuyama A., and Hashimoto H. Aberrant MAD2 expression in soft-tissue sarcoma. Pathol Int 58 (2008) 329-333
19. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
20. Takahashi T., Haruki N., Nomoto S., et al. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene 18 (1999) 4295-4300
21. Nomoto S., Haruki N., Takahashi T., et al. Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers. Oncogene 18 (1999) 7180-7183
22. Sotillo R., Hernando E., Diaz-Rodriguez E., et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11 (2007) 9-23
23. Zhang Y., Uchida M., Abe T., Nishimura H., Hayabuchi N., and Nakashima Y. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23 (1999) 670-677
24. Kondo Y., Kanai Y., Sakamoto M., Mizokami M., Ueda R., and Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32 (2000) 970-979
25. Sheu J.C., Lin Y.W., Chou H.C., et al. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan. Br J Cancer 80 (1999) 468-476
26. Salvucci M., Lemoine A., Saffroy R., et al. Microsatellite instability in European hepatocellular carcinoma. Oncogene 18 (1999) 181-187
27. Ng R.K., Lau C.Y., Lee S.M., Tsui S.K., Fung K.P., and Waye M.M. cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem Biophys Res Commun 322 (2004) 827-835
28. Rouzier R., Perou C.M., Symmans W.F., et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11 (2005) 5678-5685
29. Wang X., Jin D.Y., Wong Y.C., et al. Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 21 (2000) 2293-2297
30. Wang X., Jin D.Y., Ng R.W., et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res 62 (2002) 1662-1668